These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32220480)

  • 21. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
    Toole B; Gechtman C; Dreier J; Kuhn J; Gutierrez MR; Barrett A; Niederau C
    Clin Lab; 2015; 61(9):1303-15. PubMed ID: 26554251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry.
    Ansermot N; Fathi M; Veuthey JL; Desmeules J; Rudaz S; Hochstrasser D
    Clin Biochem; 2008 Jun; 41(9):728-35. PubMed ID: 18358834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.
    Mei S; Wang J; Chen D; Zhu L; Zhao M; Tian X; Hu X; Zhao Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():36-42. PubMed ID: 29704799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
    Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
    Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
    Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
    Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine.
    Poquette MA; Lensmeyer GL; Doran TC
    Ther Drug Monit; 2005 Apr; 27(2):144-50. PubMed ID: 15795643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of four immunosuppressive drugs in whole blood using MEPS and LC-MS/MS allowing automated sample work-up and analysis.
    Said R; Pohanka A; Abdel-Rehim M; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():42-9. PubMed ID: 22542514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
    McMillin GA; Johnson-Davis K; Dasgupta A
    Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients.
    Laverdière I; Caron P; Couture F; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():131-7. PubMed ID: 22265668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
    Morgan PE; Brown NW; Tredger JM
    Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry.
    Taylor PJ; Salm P; Lynch SV; Pillans PI
    Ther Drug Monit; 2000 Oct; 22(5):608-12. PubMed ID: 11034268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients.
    Veenhof H; Koster RA; Alffenaar JC; van den Berg AP; de Groot MR; Verschuuren EAM; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2019 Nov; 57(12):1854-1862. PubMed ID: 30939110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous Determination of Protein-Unbound Cyclosporine A and Mycophenolic Acid in Kidney Transplant Patients Using Liquid Chromatography-Tandem Mass Spectrometry.
    Bittersohl H; Herbinger J; Wen M; Renders L; Steimer W; Luppa PB
    Ther Drug Monit; 2017 Jun; 39(3):211-219. PubMed ID: 28328764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
    Pohanka A; Rosenborg S; Lindh JD; Beck O
    Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.